Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Shares Outstanding (Diluted Average) (2021 - 2025)

Cardio Diagnostics Holdings' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $1.7 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 128.21% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $1.7 million, up 128.21%, while the annual FY2024 figure was $26.9 million, 112.0% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $1.7 million at Cardio Diagnostics Holdings, up from $1.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $26.9 million in Q4 2024 and bottomed at $702574.0 in Q1 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $3.7 million (2022), against an average of $6.1 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) surged 310.83% in 2023 before it tumbled 93.64% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.2 million in 2021, then skyrocketed by 165.44% to $3.1 million in 2022, then soared by 310.83% to $12.7 million in 2023, then soared by 112.0% to $26.9 million in 2024, then crashed by 93.57% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Shares Outstanding (Diluted Average) are $1.7 million (Q3 2025), $1.7 million (Q2 2025), and $1.7 million (Q1 2025).